Back to Stakeholders
Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchIndependent Academic Research Groups
Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations
Care Delivery & Psychedelic Facilitation
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

Brigham and Women's Hospital

United States
5 Trials

Major academic medical center in Boston affiliated with Harvard Medical School and part of the Mass General Brigham health system. Researchers at BWH are active in the emerging field of psychedelic-assisted therapy, including psilocybin studies for gastrointestinal conditions and ethical frameworks for psychedelic pain research.

Academic Research

0 papers

Published Papers

0

Trial Involvement

5

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
United States
Website
Visit

Sponsored Trials

5
Not yet recruitingII

Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder

Start Date
Compounds
Psilocybin
TerminatedII

Ketamine for OUD and Suicidal Ideation in the ED

Start Date
Compounds
Ketamine, Placebo
WithdrawnII

Ketamine for the Treatment for Alcohol Use Disorder in the ED

Start Date
Compounds
Ketamine, Placebo
Enrolling by invitationIV

Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD)

Start Date
Compounds
Ketamine, Placebo
TerminatedII

MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

Start Date
Compounds
MDMA